PMID: 3753395May 1, 1986Paper

Effect of calmodulin antagonists on hypoxia and reoxygenation damage in isolated rabbit hearts

Basic Research in Cardiology
A Beresewicz, E Karwatowska-Kryńska

Abstract

The effect of calmodulin antagonists trifluoperazine (2.5 X 10(-7) M and 2.5 X 10(-6) M) and R 24571 (10(-8) M and 10(-7) M) on Langendorff-perfused rabbit hearts subjected to 180 min hypoxia and 30 min reoxygenation was studied. Coronary flow, force of contraction, oxygen consumption and release of lactate, noradrenaline and LDH were measured. Both drugs were found to reduce some of the deleterious consequences of hypoxia, i.e., they caused: marked reduction in the hypoxic LDH release; reduction in hypoxic contracture; increased recovery of active tension, oxygen consumption and coronary flow upon reoxygenation as compared to those in the untreated controls. The drugs prevented reoxygenation-induced LDH release in the drug-pretreated hearts and had no effect when given only during reoxygenation. This suggests that the drugs do not prevent reoxygenation damage as such, but only some changes developing during hypoxia, which make myocardium vulnerable to the reoxygenation damage. Although other interpretations are possible (e.g., the effects are related to the membrane stabilizing action of the drugs), our data are consistent with the hypothesis that a calmodulin-sensitive process is involved in the hypoxia damage of the myocardium.

References

Oct 1, 1978·Journal of Molecular and Cellular Cardiology·R C FransonW B Weglicki
Sep 27, 1979·Biochemical and Biophysical Research Communications·P Y Wong, W Y Cheung
Jul 1, 1979·Journal of Molecular and Cellular Cardiology·W G NaylerA Williams
Nov 21, 1975·Naunyn-Schmiedeberg's Archives of Pharmacology·K Sakai, P G Spieckermann
Jun 1, 1973·Journal of Molecular and Cellular Cardiology·G Gercken, V Döring
Jan 1, 1980·Annals of the New York Academy of Sciences·B WeissT L Wallace
Oct 1, 1980·Journal of Molecular and Cellular Cardiology·M P WalshJ G Demaille
Oct 1, 1981·Journal of Molecular and Cellular Cardiology·P M Grinwald, W G Nayler
Oct 1, 1982·Circulation Research·D K WerthA M Watanabe
Feb 1, 1984·Journal of Molecular and Cellular Cardiology·P A Poole-WilsonM A Tones
Aug 15, 1984·Archives of Biochemistry and Biophysics·M MiyaharaK Utsumi
Jul 1, 1984·Journal of Molecular and Cellular Cardiology·C Steenbergen, R B Jennings
Jan 1, 1984·General Pharmacology·C E AronsonJ F Spear
Dec 1, 1983·European Heart Journal·S W SchafferJ M McMcord
Aug 1, 1983·Journal of Molecular and Cellular Cardiology·E Karwatowska-Kryńska, A Beresewicz
Oct 15, 1981·Biochemical and Biophysical Research Communications·J A ArrudaC T Burt
Jul 15, 1981·Biochemical Pharmacology·Y LandryM Ruckstuhl
Jul 1, 1980·Circulation Research·S WallensteinJ L Fleiss
Oct 1, 1955·Proceedings of the Society for Experimental Biology and Medicine·F WROBLEWSKI, J S LADUE

❮ Previous
Next ❯

Citations

Apr 1, 1989·Naunyn-Schmiedeberg's Archives of Pharmacology·P NokinC Lugnier
Nov 1, 1989·Basic Research in Cardiology·A Beresewicz

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.